Journal ArticleOPEN ACCESS

Destroy, what destroys you

OncoImmunology (2020) 9(1)
DOI: 10.1080/2162402X.2019.1685301
4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

New evidence indicates the importance of CD137 for controlling Epstein-Barr virus (EBV) infections. (1) Mutations in CD137 predispose to EBV-associated diseases. (2) EBV induces ectopic CD137 expression, thereby activating a negative feed-back regulation and reducing T cell costimulation. These findings suggest CD137 agonists as new treatments for EBV-associated diseases.

Author supplied keywords

Cite

CITATION STYLE

APA

Luu, K., Nickles, E., & Schwarz, H. (2020). Destroy, what destroys you. OncoImmunology, 9(1). https://doi.org/10.1080/2162402X.2019.1685301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free